South Korea
· Delayed Price · Currency is KRW T Scientific Co.,Ltd. Statistics
Total Valuation
T Scientific Co.,Ltd. has a market cap or net worth of KRW 64.76 billion. The enterprise value is 58.18 billion.
| Market Cap | 64.76B |
| Enterprise Value | 58.18B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
T Scientific Co.,Ltd. has 71.25 million shares outstanding. The number of shares has increased by 23.36% in one year.
| Shares Outstanding | 71.25M |
| Shares Change (YoY) | +23.36% |
| Shares Change (QoQ) | +2.90% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 4.04% |
| Float | 47.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.78 |
| PB Ratio | 0.45 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.78 |
| EV / Sales | 1.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.31 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.33 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.57 |
| Interest Coverage | -4.56 |
Financial Efficiency
Return on equity (ROE) is -21.29% and return on invested capital (ROIC) is -2.16%.
| Return on Equity (ROE) | -21.29% |
| Return on Assets (ROA) | -1.82% |
| Return on Capital (ROIC) | -2.16% |
| Revenue Per Employee | 185.31M |
| Profits Per Employee | -174.32M |
| Employee Count | 188 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 53.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.74% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -67.74% |
| 50-Day Moving Average | 961.74 |
| 200-Day Moving Average | 1,290.74 |
| Relative Strength Index (RSI) | 47.06 |
| Average Volume (20 Days) | 1,842,066 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, T Scientific Co.,Ltd. had revenue of KRW 34.84 billion and -32.77 billion in losses. Loss per share was -479.78.
| Revenue | 34.84B |
| Gross Profit | 8.01B |
| Operating Income | -6.25B |
| Pretax Income | -41.47B |
| Net Income | -32.77B |
| EBITDA | -4.85B |
| EBIT | -6.25B |
| Loss Per Share | -479.78 |
Balance Sheet
The company has 10.83 billion in cash and 5.23 billion in debt, giving a net cash position of 5.60 billion or 78.56 per share.
| Cash & Cash Equivalents | 10.83B |
| Total Debt | 5.23B |
| Net Cash | 5.60B |
| Net Cash Per Share | 78.56 |
| Equity (Book Value) | 143.16B |
| Book Value Per Share | 2,023.13 |
| Working Capital | 9.71B |
Cash Flow
In the last 12 months, operating cash flow was -9.05 billion and capital expenditures -170.44 million, giving a free cash flow of -9.22 billion.
| Operating Cash Flow | -9.05B |
| Capital Expenditures | -170.44M |
| Free Cash Flow | -9.22B |
| FCF Per Share | -129.38 |
Margins
Gross margin is 23.00%, with operating and profit margins of -17.93% and -94.07%.
| Gross Margin | 23.00% |
| Operating Margin | -17.93% |
| Pretax Margin | -119.02% |
| Profit Margin | -94.07% |
| EBITDA Margin | -13.93% |
| EBIT Margin | -17.93% |
| FCF Margin | -26.46% |
Dividends & Yields
T Scientific Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.36% |
| Shareholder Yield | -23.36% |
| Earnings Yield | -52.78% |
| FCF Yield | -14.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
T Scientific Co.,Ltd. has an Altman Z-Score of 2.25. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.25 |
| Piotroski F-Score | n/a |